Imiquimod: a topically applied link between innate and acquired immunity.
Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA.
Daniel J
DJ
Hurwitz
Laura
L
Pincus
Thomas S
TS
Kupper
D000276:Adjuvants, Immunologic / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000287:Administration, Topical; D000634:Aminoquinolines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000077271:Imiquimod; D007110:Immunity, Active / Q000187:drug effects*; D007113:Immunity, Innate / Q000187:drug effects*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod